Source:http://linkedlifedata.com/resource/pubmed/id/11966713
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2002-4-22
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
0007-0963
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
146
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
707-9
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:11966713-Antibodies, Monoclonal,
pubmed-meshheading:11966713-Dermatologic Agents,
pubmed-meshheading:11966713-Epidermal Necrolysis, Toxic,
pubmed-meshheading:11966713-Female,
pubmed-meshheading:11966713-Humans,
pubmed-meshheading:11966713-Middle Aged,
pubmed-meshheading:11966713-Tumor Necrosis Factor-alpha
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis.
|
| pubmed:publicationType |
Letter,
Case Reports
|